Ischemix
Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
26
organic / mo
Sign up free to see all 6 verified contacts at Ischemix
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- DD
David Dewahl
President and Chief Executive Officer · Other
EmailPhone - GE
Geoffrey E. Clark
Medical Director · Healthcare & Human Services
EmailPhone - SK
Steven Kates
VP, R & d · Research & Development
EmailPhone - JS
Jerry Stern
Chief Medical Officer · Healthcare & Human Services
EmailPhone
Showing 4 of 6 verified contacts
Top roles at Ischemix
6 distinct titles indexed · top 6 shown.
- 1chief medical officer
- 1isch
- 1medical director
- 1president and chief executive officer
- 1research associate
- 1vp, r & d
Sign up to unlock all 6 contacts at Ischemix
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Ischemix
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.